Abstract:Background: Hepatocellular carcinoma (HCC) is a highly heterogeneous disease with high morbidity and mortality, which accounts for the fourth most common cause of cancer-related deaths. Reports suggest that the neurotransmitter receptor-related genes (NRGs) may influence the tumor microenvironment and the prognosis of patients with HCC. Methods: The clinical information and RNA-seq data of patients with HCC were acquired from the ICGC-LIRI-JP dataset and the TCGA-LIHC dataset. Effects of 115 NRGs on the prognosis of HCC patients were analyzed in the ICGC-LIRI-JP dataset. The least absolute shrinkage and selection operator (LASSO) regression model was utilized to generate a risk score formula based on the critical NRGs. Next, the risk score effectiveness was validated both in the TCGA-LIHC dataset and in our clinical HCC samples. Based on the risk scores, patients with HCC were divided into two groups. Moreover, differentially expressed genes (DEGs) were screened. The gene ontology (GO) was used to analyze the functional enrichments of DEGs and to identify potential signaling pathways. To test the diagnostic effectiveness of our model, the receiver operator characteristic curve (ROC) analysis and nomogram were used. Finally, potential targeted drug prediction was performed based on DEGs of nine clinical HCC samples. Results: Nine NRGs were correlated significantly with the prognosis of patients with HCC, and eight NRGs were successfully included in the LASSO regression model. The Kaplan-Meier analysis of overall survival (OS) suggested that patients in the high-risk score group had worse prognosis; on the other hand, ROC analysis revealed a high prognostic value of the risk score in HCC. Several critical signaling pathways, such as lipid metabolism, organic acid metabolism, cell migration, cell adhesion, and immune response, were enriched both in public datasets and clinical samples. Nomogram results also suggested that the risk scores correlated well with the patients' prognosis. Potential targeted drugs prediction revealed that tubulin inhibitors might be the promising drugs for patients with HCC who have high risk scores based on the NRGs. Conclusion: We established a prognostic model based on critical NRGs. NRGs show a promising prognostic prediction value in HCC and are potential therapeutic targets for the disease treatment.

Nogo-C Contributes to HCC Tumorigenesis Via Suppressing Cell Growth and Its Interactome Analysis with Comparative Proteomics Research.

Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma.

Prognostic and Biological Role of the N-Myc Downstream-Regulated Gene Family in Hepatocellular Carcinoma.

Nogo‐B Promotes Tumor Angiogenesis and Provides a Potential Therapeutic Target in Hepatocellular Carcinoma

Role of Nogo‑A in the Regulation of Hepatocellular Carcinoma SMMC‑7721 Cell Apoptosis.

Nogo‐B: A Potential Indicator for Hepatic Cirrhosis and Regulator in Hepatic Stellate Cell Activation

Identification of CCDC115 As an Adverse Prognostic Biomarker in Liver Cancer Based on Bioinformatics and Experimental Analyses

Upregulation of Nogo-B by hypoxia inducible factor-1 and activator protein-1 in hepatocellular carcinoma

Nogo-B Promotes Invasion and Metastasis of Nasopharyngeal Carcinoma Via RhoA-SRF-MRTFA Pathway.

LINC00844 Promotes Proliferation and Migration of Hepatocellular Carcinoma by Regulating NDRG1 Expression

N-Myc Downstream-Regulated Gene 1 Inhibits The Proliferation And Invasion Of Hepatocellular Carcinoma Cells Via The Regulation Of Integrin Beta 3

Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway

Human Nogo-C overexpression induces HEK293 cell apoptosis via a mechanism that involves JNK-c-Jun pathway.

Comprehensive analysis of the role of netrin G1 (NTNG1) in hepatocellular carcinoma cells.

SNHG16 Promotes Hepatocellular Carcinoma Development Via Activating ECM Receptor Interaction Pathway.

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma

CNDP1 Suppresses the Malignant Behavior of Hepatoma Cell via Restricting PI3K-AKT-mTOR Activation

The Nociceptin Receptor Promotes Autophagy Through NF-kB Signaling and is Transcriptionally Regulated by E2F1 in HCC

NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma

c-Jun-dependent β3GnT8 promotes tumorigenesis and metastasis of hepatocellular carcinoma by inducing CD147 glycosylation and altering N -glycan patterns.